ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 2.03M EUR in the quarter ending March 31, 2026, a decrease of -57.12%. This brings the company's revenue in the last twelve months to 13.64M, down -30.51% year-over-year. In the year 2025, ProQR Therapeutics had annual revenue of 16.35M, down -16.36%.

• Revenue (ttm): 13.64M EUR
• Revenue Growth: -30.51%
• P/S Ratio: 10.45
• Revenue / Employee: 73,092 EUR
• Employees: 187
• Market Cap: 164.37M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.35M	-3.20M	-16.36%
Dec 31, 2024	19.55M	10.02M	105.20%
Dec 31, 2023	9.53M	5.17M	118.51%
Dec 31, 2022	4.36M	1.98M	83.31%
Dec 31, 2021	2.38M	-7.07M	-74.84%
Dec 31, 2020	9.45M	7.52M	388.98%
Dec 31, 2019	1.93M	-3.83M	-66.45%
Dec 31, 2018	5.76M	4.27M	285.35%
Dec 31, 2017	1.50M	-333.00K	-18.22%
Dec 31, 2016	1.83M	-1.41M	-43.49%
Dec 31, 2015	3.24M	2.92M	933.55%
Dec 31, 2014	313.00K	197.00K	169.83%
Dec 31, 2013	116.00K	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error